Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...
A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...
Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help ...
Scientists have identified a new cell type and discovered that many normal-looking prostate cells already harbour cancer-related changes.Prostate ...
Researchers are developing genomic screening tools to tailor radiation dose and hormone therapy for prostate cancer patients, ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
The 2026 PSMA & Beyond conference featured a targeting the cell surface session and presentation by Dr. Tanya Dorff discussing antibody drug conjugates and BiTEs and their role in prostate cancer. Dr.